Clinical trials in Aalborg – page 4

330 clinical trials in Aalborg, Denmark across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in DenmarkKliniske-Forsoeg.dk

Aalborg at a glance

330

clinical trials

Research sites4

Quick filters

330 trials in Aalborg

Open in trial search

Bipolar I disorder+1

Recruiting

A study testing xanomeline tartrate and trospium chloride added to current treatment for adults with bipolar I disorder experiencing mania

Investigational

A study testing xanomeline tartrate and trospium chloride added to current treatment for adults with bipolar I disorder experiencing mania

Investigational

Denmark

Participants:18–64 years
Substances:Trospium Chloride
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

HIV infection

Recruiting

A Study of Venetoclax in People with HIV-1 Infection Starting Antiretroviral Treatment to Reduce the HIV Reservoir

Registered drugNo placebo

A Study of Venetoclax in People with HIV-1 Infection Starting Antiretroviral Treatment to Reduce the HIV Reservoir

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Venetoclax
Sponsor:Region Midtjylland

Contact Research Centre

Pancreatic carcinoma metastatic+1

Recruiting

A Study of BMS-986504 Combined with Nab-Paclitaxel and Gemcitabine for Patients with Untreated Metastatic Pancreatic Cancer with MTAP Gene Deletion

Registered drug

A Study of BMS-986504 Combined with Nab-Paclitaxel and Gemcitabine for Patients with Untreated Metastatic Pancreatic Cancer with MTAP Gene Deletion

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Gemcitabine
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Depemokimab
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Breast cancer+2

Recruiting

A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Registered drugNo placebo

A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Capivasertib
Sponsor:Relay Therapeutics Inc.

Contact Research Centre

Endometrial cancer+1

Recruiting

A study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment

Registered drugNo placebo

A study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:DB-1303
Sponsor:BioNTech SE

Contact Research Centre

A study of drug combination (clopidogrel, acetylsalicylic acid, atorvastatin, rosuvastatin) for patients with covert brain infarction

Recruiting

Registered drugNo placebo

A study of drug combination (clopidogrel, acetylsalicylic acid, atorvastatin, rosuvastatin) for patients with covert brain infarction

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Region Midtjylland

Contact Research Centre

Acute myocardial infarction

Recruiting

Study of ziltivekimab compared to placebo in patients with acute heart attack to evaluate its effects on coronary artery plaque reduction

Investigational

Study of ziltivekimab compared to placebo in patients with acute heart attack to evaluate its effects on coronary artery plaque reduction

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:Ziltivekimab
Sponsor:ECRI-trials B.V.

Contact Research Centre

Bipolar I disorder+1

Recruiting

Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder

InvestigationalNo placebo

Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Trospium Chloride
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

General anaesthesia+1

Recruiting

Comparison of remifentanil and rocuronium for improving video laryngoscopy assisted tracheal intubation in adult patients undergoing general anesthesia

Registered drugNo placebo

Comparison of remifentanil and rocuronium for improving video laryngoscopy assisted tracheal intubation in adult patients undergoing general anesthesia

Registered drugNo placebo

Denmark

Participants:18–64 years
Substances:Rocuronium Bromide
Sponsor:Nordsjaellands Hospital

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Study of dupilumab injections to reduce airway inflammation in adults aged 40-85 with chronic obstructive pulmonary disease

Registered drug

Study of dupilumab injections to reduce airway inflammation in adults aged 40-85 with chronic obstructive pulmonary disease

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Dupilumab
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Primary mediastinal large B-cell lymphoma+3

Recruiting

Study of dapagliflozin to prevent heart complications during lymphoma treatment in patients receiving first-line therapy

Registered drug

Study of dapagliflozin to prevent heart complications during lymphoma treatment in patients receiving first-line therapy

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Placebo
Sponsor:Aalborg University Hospital

Contact Research Centre

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Aalborg

What the registry says about research in the country

01 Oncology Studies

Innovative research focusing on endometrial cancer and metastatic prostate cancer treatments. Studies evaluating new therapeutic combinations and investigating cannabidiol's potential in cancer care.

Advanced breast cancer therapy evaluation
Cancer-related fatigue management
Novel drug combinations assessment

Multiple trials exploring targeted therapies and quality of life improvements for cancer patients.

02 Immunology & Infectious Diseases

Comprehensive studies on meningococcal vaccines and chickenpox prevention in children. Research includes RSV prevention and inflammatory conditions.

Vaccine immunogenicity studies
Chronic rhinosinusitis treatments
Plaque psoriasis therapies

Focus on preventive medicine and immune system responses in various age groups.

03 Gastrointestinal & Metabolic Disorders

Investigations into inflammatory bowel diseases including studies on Crohn's Disease and Ulcerative Colitis. Research on opioid-induced bowel dysfunction.

Therapeutic drug monitoring
Bowel dysfunction treatments
Novel therapeutic combinations

Advancing understanding of digestive system disorders and their management.

04 Cardiovascular & Renal Studies

Research on chronic kidney disease treatments and heart failure prevention. Studies examining new approaches for cardiovascular disease management.

Heart failure prevention strategies
Kidney disease therapies
Cardiovascular risk reduction

Innovative approaches to managing complex cardio-renal conditions.

05 Neurological & Psychiatric Research

Studies investigating treatments for amyotrophic lateral sclerosis and dual diagnosis of schizophrenia with alcohol use disorder.

ALS treatment development
Psychiatric disorder management
Neurological disease therapies

Exploring new therapeutic options for complex neurological and psychiatric conditions.

Back to Denmark All countries